EUVIMEDEUVIMED entdecken
Fallbericht

Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae

Maria Mazzitelli iD, Marco Coppi, Vincenzo Scaglione, Lorenzo Paci, Ignazio Castagliuolo, Elisa Franchin, Gian Masria Rossolini, Annamaria Cattelan

Journal of Antimicrobial Chemotherapy · 03.09.2025 · 80 (9) · 2442-2446

DOI: 10.1093/jac/dkaf238 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 17.07.2025. Verfasst von Maria Mazzitelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, beta-Lactamases, Cephalosporins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: PRIN 2022, 2022WBPFSC, MIUR-Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We describe the clinical and microbiological features of four cases of bacteraemia caused by cefiderocol-resistant NDM-producing Klebsiella pneumoniae (NDM-KP), observed at Padua University Hospital, Italy, in four immunocompromised hosts not previously exposed to cefiderocol.

Methods

Three out of the four cefiderocol-resistant NDM-KP isolates also co-produced OXA-48-like carbapenemases. Cefiderocol susceptibility testing was performed both alone or in combination with EDTA or xeruborbactam, used as NDM inhibitors, following reference microdilution methods in iron-depleted Mueller–Hinton broth. Whole-genome sequencing was conducted to investigate the resistome, virulome, MLST and plasmidome.

Results

All patients reported isolates with a primary resistance to cefiderocol. In two cases, clinical failure to cefiderocol occurred before susceptibility results were available. All patients were successfully treated with the aztreonam-avibactam combination. MLST revealed that two isolates belonged to ST14 and two to ST147. No known alterations in iron uptake systems were detected by whole-genome sequencing. However, both ST14 NDM-KP carried a fec operon located on an IncFIIK-IncFIBk plasmid. The addiction of EDTA or xeruborbactam restored cefiderocol susceptibility, suggesting a key role of NDM-1 production in mediating resistance.

Conclusions

This case series highlights the urgent need of new therapeutic agents that will overcome the diffusion of NDM-KP resistant to FDC. The emergence of NDM-KP with an acquired fec operon in nosocomial settings, even without a previous drug exposure, may further compromise cefiderocol efficacy. Further studies will be necessary to assess the in vivo activity of xeruborbactam, a new cyclic boronate β-lactamase inhibitor, which may restore cefiderocol susceptibility in NDM-KP isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteremiabeta-LactamasesCephalosporinsKlebsiella InfectionsKlebsiella pneumoniaeAgedFemaleHumansMaleMiddle AgedBacterial ProteinsCefiderocolItalyMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsWhole Genome SequencingAdult

Substanzen

Anti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCefiderocolCephalosporins

Autor:innen und Institutionen

  • Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
  • Microbiology and Virology Unit, Padua University Hospital, Padua, Italy.

ORCID-Profile: Maria Mazzitelli

Förderung

  • PRIN 2022
  • 2022WBPFSC
  • MIUR-Italy

Zitieren

APA

Mazzitelli, M., Coppi, M., Scaglione, V., Paci, L., Castagliuolo, I., Franchin, E., Rossolini, G. M., & Cattelan, A. (2025). Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy, 80(9), 2442-2446. https://doi.org/10.1093/jac/dkaf238

Vancouver

Mazzitelli M, Coppi M, Scaglione V, Paci L, Castagliuolo I, Franchin E, et al. Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 2025;80(9):2442-2446. doi:10.1093/jac/dkaf238

BibTeX
@article{Mazzitelli2025,
  author = {Mazzitelli, Maria and Coppi, Marco and Scaglione, Vincenzo and Paci, Lorenzo and Castagliuolo, Ignazio and Franchin, Elisa and Rossolini, Gian Masria and Cattelan, Annamaria},
  title = {Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {9},
  pages = {2442--2446},
  doi = {10.1093/jac/dkaf238}
}
Kostenlos starten →